<DOC>
	<DOCNO>NCT00736658</DOCNO>
	<brief_summary>This single centre , double-blind , randomise , parallel group , placebo control study ass safety , tolerability pharmacokinetics AZD1386 give multiple dos 32 ( 24 healthy young 8 healthy elderly ) Japanese subject . For young healthy subject ( age ≥20 ≤45 inclusive ) 3 consecutive multiple ascend dose panel plan . For elderly healthy subject ( age ≥65 to≤80 inclusive ) 1 multiple dose panel plan .</brief_summary>
	<brief_title>AZD1386 Japanese Multiple Ascending Dosing Study</brief_title>
	<detailed_description />
	<mesh_term>Chronic Pain</mesh_term>
	<criteria>Healthy Japanese male female young ( ≥20 ≤45 year inclusive ) elderly ( ≥65 ≤80 year inclusive ) . Female subject must surgically sterile postmenopausal . Body Mass Index ( BMI ) ≥19 ≤ 27 kg/m2 weight ≥45 ≤90 kg Clinically normal physical finding include heart rate &gt; 45 bpm laboratory value normal rest ECG History somatic psychiatric disease/condition , may interfere objective study judge investigator A family history short long QT syndrome ( SQTS ) sudden cardiac death ( SCD ) amongst first degree relative Subjects orthostatic hypotension define decrease ≥ 25mmHg systolic blood pressure and/or decrease ≥15mmHg diastolic blood pressure within 5 minute go supine stand position Clinically significant illness clinically relevant trauma within 2 week prior administration investigational product judge investigator</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Japanese</keyword>
	<keyword>MAD</keyword>
	<keyword>Multiple ascend dose</keyword>
	<keyword>Chronic pain</keyword>
</DOC>